← All stories
Markets
Medicenna to Present at the H.C. Wainwright 28th Annual Global Investment Conference
TORONTO and HOUSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer,…
Covered by 1 outlet
All coverage · 1 article